共找到 4 份报告搜索:Medicare Part D
How will a Rebate Model Impact Cash Flow for Price Negotiated Drugs in Medicare Part D?
IQVIA2025-12-2718 页
内卷之下,交易升温:MNC 创新竞争升级——减重药物行业深度报告(下)
麦高证券2026-02-0230 页
China Pharma and Biotech: Top investor questions from marketing meetings answered
Bernstein2026-01-2923 页
中国医药 - 全球减重药物市场:千亿蓝海与创新迭代
招银国际环球市场2026-03-2521 页